Taubman Institute-Israel Initiative
The Taubman Institute has launched an initiative to establish collaborations between leading medical researchers in Michigan and their colleagues in Israel. The impetus behind the effort came from a trip to medical research facilities in Israel that Alfred Taubman took in 2008 with Institute Director Eva Feldman, M.D., Ph.D., and Institute Co-Chair Gayle Taubman Kalisman, Ed.D.
“We were very impressed by the ground-breaking research being done in Israel,” said Alfred Taubman. “And we immediately recognized the opportunities for collaboration between U of M and the talented scientists in Israel.”
To encourage the exchange of medical knowledge, the Institute has held two A. Alfred Taubman Lectureships at the University of Michigan, presented by preeminent Israeli stem cell researchers:
- Miguel Weil, Ph.D., profession of life sciences at Tel Aviv University spoke on September 17, 2008. The title of his talk was “Mesenchymal Stem Cells in Regenerative Medicine.”
- Benjamin Reubinoff, M.D., Ph.D., professor of neurology at Hadassah Medical Center presented his lecture on January 2009. One of the world’s pioneers in embryonic stem cell science, he spoke on the topic: “Human Embryonic Stem Cells: A Promising Therapy for Neurological Disorders.”
Both lectures were very well attended by U-M researchers. Preceding the talks, a reception was held for members of the University of Michigan and local Jewish communities. In addition, following Dr. Reubinoff’s lecture, the Greater Detroit Chapter of Hadassah sponsored a luncheon in his honor.
The Taubman Institute will continue to build relationships and joint projects with eminent Israeli scientists.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars Symposium set for April 29
Annual showcase of early career physician-researchers runs 10 a.m. to noon at the A. Alfred Taubman Biomedical Science Research Building.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results